Cambridge, UK-based Sense Biodetection—or Sense—has raised a $15.8 million Series A funding round, as it scales out its portfolio of molecular diagnostics products. The round, led by Cambridge Innovation Capital and Earlybird…
Proscia is Fighting Cancer with Artificial Intelligence
It is a centuries-old image of good science: the lab-coated expert, hunched over a microscope analyzing a glass slide. Proscia wants to resign it to history – at least, when it comes…